Yingying Peng, Hanlin Jiang, Bifei Li, Yue Liu, Bing Guo, & Wei Gan. (2023). A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. MDPI AG.
Chicago Style (17th ed.) CitationYingying Peng, Hanlin Jiang, Bifei Li, Yue Liu, Bing Guo, and Wei Gan. A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. MDPI AG, 2023.
MLA (9th ed.) CitationYingying Peng, et al. A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.